News GlobeNewswire Enlivex to Present 3-Month Topline Data from Phase IIa Moderate/Severe Knee Osteoarthritis Trial on August 18 Webinar ...

CAMBRIDGE, Mass., Aug. 13, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase ...

The decision adds to the challenges for Nayara Energy, coming soon after technology giant Microsoft Corporation denied the company access to its data services last month over the same issue.

Nuvalent to Present Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025 Presidential Symposium ...

Microsoft Excel now lets you run Python scripts on images to detect sharpness, edit visuals, and analyze metadata.